Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Modesto
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Modesto, CA

Studies commonly pay $75 to $4,500 per completed study

105 clinical trials are currently recruiting participants within 30 miles of Modesto. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

105studies recruiting
3+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Modesto right now

Top 25 of 105 recruiting studies, sorted by proximity — each links to its official registry page

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Breast Neoplasms, Carcinoma, Ductal, Breast N/A Interventional 725 participants sought
Stockton Hematology Oncology Medical Group — Stockton, California (27.1 mi) · Sponsor: Natera, Inc.

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Renal Pelvis and Ureter Urothelial Carcinoma Phase 2, Phase 3 Interventional 131 participants sought
Memorial Medical Center — Modesto, California (0.3 mi) · Sponsor: National Cancer Institute (NCI)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Memorial Medical Center — Modesto, California (0.3 mi) · Sponsor: NRG Oncology

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

SpO2 N/A Interventional 100 participants sought
Paradigm Clinical Research — Modesto, California (0.3 mi) · Sponsor: Masimo Corporation

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Memorial Medical Center — Modesto, California (0.3 mi) · Sponsor: National Cancer Institute (NCI)

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Migraine Phase 3 Interventional 1,059 participants sought
Paradigm Clinical Research - Modesto, CA /ID# 280611 — Modesto, California (0.3 mi) · Sponsor: AbbVie

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi) · Sponsor: National Cancer Institute (NCI)

Vancomycin Reduction Practices (VRP) in the NICU

Antibiotic Stewardship, Neonatal Sepsis, Late-Onset N/A Interventional 13 participants sought
Kaiser Permanente Modesto Medical Center — Modesto, California (0.3 mi) · Sponsor: Children's Hospital of Philadelphia

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought
Memorial Medical Center — Modesto, California (0.3 mi) · Sponsor: NRG Oncology

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
Memorial Medical Center — Modesto, California (0.3 mi) · Sponsor: SWOG Cancer Research Network

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1 Phase 3 Interventional 150 participants sought
Paradigm Clinical Research - Modesto — Modesto, California (0.3 mi) · Sponsor: vTv Therapeutics

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathic Pain Phase 3 Interventional 734 participants sought
Paradigm Clincial Research - Modesto — Modesto, California (0.3 mi) · Sponsor: Vertex Pharmaceuticals Incorporated

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi) · Sponsor: National Cancer Institute (NCI)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Phase 3 Interventional 1,978 participants sought
Memorial Medical Center — Modesto, California (0.3 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration, nAMD Phase 3 Interventional 304 participants sought
Retinal Consultants Medical Group, Inc - Modesto (RCA) — Modesto, California (0.3 mi) · Sponsor: Amgen

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Memorial Medical Center — Modesto, California (0.3 mi) · Sponsor: National Cancer Institute (NCI)

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos N/A Interventional 535 participants sought
Saint Joseph's Medical Center — Stockton, California (27.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Phase 3 Interventional 304 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi) · Sponsor: National Cancer Institute (NCI)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Memorial Medical Center — Modesto, California (0.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought
Memorial Medical Center — Modesto, California (0.3 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Phase 2 Interventional 156 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi) · Sponsor: National Cancer Institute (NCI)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi) · Sponsor: National Cancer Institute (NCI)
Actively enrolling

Studies you may be able to join near Modesto

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Modesto

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Central Valley Research

★ 4.9
400 E Orangeburg Ave Ste 5, Modesto, CA 95350
(209) 549-9538

Paradigm Clinical Research

★ 5.0
1108 Oakdale Rd Ste C, Modesto, CA 95355
(209) 554-4844
"Loved the cleanliness and the kindness of the staff! Highly recommend!"
— Anabelle Santiago, 5★

Clinical Research: 600 Coffee Road Clinic: Sutter Gould Medical Foundation

600 Coffee Rd, Modesto, CA 95355
(209) 521-6097 ext. 3214

Clinical trials in Modesto: what's recruiting

The Modesto area currently has 105 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Modesto, the most active research areas are:

  • Cancer & Oncology17 studies
  • Liver & Kidney3 studies
  • Diabetes & Metabolism2 studies
  • Immune & Skin1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Modesto, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Modesto

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Modesto participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Modesto pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Modesto?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Modesto safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Modesto, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Modesto?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Modesto

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of CA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts